International Journal of Gynecological Cancer

Papers
(The H4-Index of International Journal of Gynecological Cancer is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-08-01 to 2024-08-01.)
ArticleCitations
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma972
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)235
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer177
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer157
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*115
ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer90
Clear cell carcinoma of the ovary: a clinical and molecular perspective87
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy86
Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-171
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors66
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program63
Human papillomavirus-independent cervical cancer57
Evaluating meaningful levels of financial toxicity in gynecologic cancers53
Management of pregnancy in women with cancer52
European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery50
Global challenges of radiotherapy for the treatment of locally advanced cervical cancer48
Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: an international survey of peri-operative practice47
Uterine serous carcinoma: key advances and novel treatment approaches46
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 202345
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment follo44
Advances in immunotherapy for cervical cancer: recent developments and future directions42
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification42
SUCCOR cone study: conization before radical hysterectomy40
Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes40
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-00138
Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management36
Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective35
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer34
ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)33
Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analysis of predictors of failed mapping31
Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer31
0.16953992843628